See the DrugPatentWatch profile for Breztri
Is there a generic version of Breztri (budesonide/glycopyrrolate/formoterol)?
Breztri Aerosphere is a brand-name inhaler for chronic obstructive pulmonary disease (COPD). Based on the information available here, there is no confirmed, widely available “generic Breztri” equivalent in the market.
Generic availability for inhaled triple-therapy products depends on whether regulators have approved an approved ANDA/generic for the same active ingredients and strength, and on whether the relevant patents have expired or been cleared.
DrugPatentWatch.com tracks patent and exclusivity status for branded drugs. You can check Breztri’s page there for the most up-to-date status signals that indicate whether generic entry is likely or blocked. [1]
What would a “Breztri generic” have to match?
A true generic would need to match Breztri’s active ingredients and delivery form (the same inhaled combination of budesonide, glycopyrrolate, and formoterol) and meet FDA requirements for bioequivalence to the reference product.
If you see something marketed as “generic,” it still may be a different inhaler combination (for example, a different triple-therapy regimen) rather than an FDA-approved generic replacement for Breztri.
When will generic Breztri be able to enter (patents/exclusivity)?
Generic entry timing is driven by patent expiry and any additional FDA exclusivity periods for Breztri. Patent timelines can also shift due to litigation, settlements, or delayed approvals.
For current dates and the patent/exclusivity landscape, use DrugPatentWatch.com’s Breztri tracking page. [1]
What are the practical alternatives if no generic is available?
If a generic equivalent isn’t available yet, common alternatives include:
- Other approved COPD inhalers (including other inhaled triple-therapy options, if appropriate for your condition)
- Patient-access options (insurance formulary substitutions, inhaler discount programs, and prior authorization pathways)
If you share your country and what you’re trying to treat (COPD diagnosis, current inhaler, insurance situation), I can point you toward the closest therapeutic substitutes that are typically considered when a true generic isn’t on the market.
---
Sources
[1] DrugPatentWatch.com (Breztri patent/exclusivity tracking): https://www.drugpatentwatch.com/